{"id":1056788,"date":"2026-06-29T04:37:15","date_gmt":"2026-06-29T04:37:15","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/1056788\/"},"modified":"2026-06-29T04:37:15","modified_gmt":"2026-06-29T04:37:15","slug":"practitioner-only-probiotic-firm-biome-australia-assessing-china-entry","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/1056788\/","title":{"rendered":"Practitioner-only probiotic firm Biome Australia assessing China entry"},"content":{"rendered":"<p class=\"c-paragraph b-article-body-skinny\">One of the biggest transformations, said Founder, CEO and Managing Director Blair Vega Norfolk, was how cross-border e-commerce (CBEC) platforms like JD Health and Tmall are focusing more on engaging healthcare professionals, instead of simply celebrities or online influencers, when promoting health products. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">This increasing focus on healthcare professionals aligns with Biome Australia\u2019s <a href=\"https:\/\/www.nutraingredients.com\/Article\/2023\/09\/04\/biome-australia-healthcare-practitioner-awareness-of-the-microbiome-key-for-success\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.nutraingredients.com\/Article\/2023\/09\/04\/biome-australia-healthcare-practitioner-awareness-of-the-microbiome-key-for-success\/\">practitioner-only approach. <\/a><\/p>\n<p class=\"c-paragraph b-article-body-skinny\">In the meantime, the company has also built up its brand reputation and consumer base in its domestic Australian market. In fact, the brand is said to have surpassed some popular retail brands in pharmacies to become the number one brand in terms of volume. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">In Australia, about 30,000 to 40,000 health professionals are already on board in recommending Biome Australia\u2019s probiotics.<\/p>\n<p class=\"c-paragraph b-article-body-skinny\">With a strong foundation at home and an increasingly healthcare-professional-focused CBEC sector in China, Norfolk said China is a market the company watches as part of its long-term international growth plans, while stressing that no call has been made to enter. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cFor so long, China has been this big celebrity-driven market and there have been big demand spikes that come on and off,\u201d said Norfolk at the recent Healthplex Expo 2026 held in Shanghai from June 15 to 17. \u201cHowever, this market in probiotics is steadier because of its growing scientific evidence and the way the CBEC companies are evolving, I think they are creating new opportunities for more premium brands, more high-quality, more evidence-based brands to be able to support Chinese consumers.\u201d<\/p>\n<p class=\"c-paragraph b-article-body-skinny\">Aside from CBECs, the company has also received interest from distributors, raw material suppliers and manufacturers keen on distributing the products. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cTo be clear, we have not made a decision to go into China. However, there is a lot of interest from the major CBEC and trade partner companies, because, as you know, they are always interested in the brands that Australians use. And now we\u2019re one of the leading brands used and preferred by Australians,\u201d he said.<\/p>\n<p>Transformation in China\u2019s probiotic market <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">Another major transformation in the Chinese probiotic market is a greater awareness of strain specificity and health benefits beyond gut health. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cDuring my first time in Shanghai, about seven or eight years ago, there were no mentions of strain specificity or clinical trials when I met with some of the probiotic manufacturers. The discussion was just on gut health,\u201d Norfolk said. \u201cThese days, the Chinese consumers are learning so much faster than anyone else in the world with all these different digital platforms. They are hungry for information, and the rate of probiotics adoption is so much faster here.\u201d<\/p>\n<p class=\"c-paragraph b-article-body-skinny\">Against this backdrop, the company sees opportunities in introducing its <a href=\"https:\/\/www.nutraingredients.com\/Article\/2019\/09\/16\/Probiotics-newcomer-Australia-s-Activated-Nutrients-seeks-to-build-reputation-for-precision-products-on-back-of-bumper-pharmacy-deal\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.nutraingredients.com\/Article\/2019\/09\/16\/Probiotics-newcomer-Australia-s-Activated-Nutrients-seeks-to-build-reputation-for-precision-products-on-back-of-bumper-pharmacy-deal\/\">condition-specific and strain-specific probiotics <\/a>to the Chinese market. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">Working with suppliers such as AB-Biotics, Probi and Probiotical, the company has developed 15 SKUs so far under the brand Activated Probiotics. Its probiotics apply to issues across immunity, iron absorption, osteopenia, osteoporosis, exercise recovery, acne, dyspepsia and more. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cThe problem with multi-strain, high-dose, generic probiotics is that all they are doing is they are like a multivitamin. They are not really doing anything specific, and they might not even be doing anything,\u201d he said. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">These products, he said, could serve as specific tools that healthcare practitioners to use to help their patients. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cEach of these condition-specific probiotic formulations is like a new item in the toolkit and we are enabling doctors to be more effective for their patients. These are not just a probiotic product for sale, which is why we need to be careful in managing the brand such that it does not become another heavily discounted item that platforms use to compete for sale,\u201d he said. <\/p>\n<p>North America expansion <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">Outside of Asia-Pacific, Biome Australia is already present in Canada with doctors, naturopaths, behind-the-counter in pharmacies and health food stores. It is now assessing market opportunities down south in America. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\"><a href=\"https:\/\/www.nutraingredients.com\/Article\/2026\/02\/12\/symprove-bought-by-metagenics-in-uk-expansion-move\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.nutraingredients.com\/Article\/2026\/02\/12\/symprove-bought-by-metagenics-in-uk-expansion-move\/\">Metagenics\u2019 <\/a>retreat from the practitioner-only health supplements category to focus on <a href=\"https:\/\/www.metagenics.com\/en-us\/faq\/about-us\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.metagenics.com\/en-us\/faq\/about-us\">direct-to-consumer retail in the US after 2023 <\/a>has created what Norfolk said was \u201ca massive gap in the US practitioner market.\u201d This also means opportunities for practitioner-only brands like Activated Probiotics to set foot in the US. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cDoctors and naturopaths have a sense of ownership or entitlement around professional brands or practitioner brands. They tend to be less supportive of brands that are accessible to the public on Amazon, supermarkets or grocery stores,\u201d he told NI. \u201cThere are about 150,000 integrative doctors in North America that prescribe probiotics to patients, which means it is the biggest market for a practitioner brand like Activated Probiotics.\u201d<\/p>\n<p>New strains and products<\/p>\n<p class=\"c-paragraph b-article-body-skinny\">On new product development, the company has lodged patents and is conducting human clinical trials on a new strain known as Lactiplantibacillus plantarum BMB18. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">This strain, Norfolk said, is planned to be used in 10 of its products as a \u201cpower strain\u201d, given the company\u2019s IP ownership. Clinical studies on its effects for irritable bowel syndrome (IBS) and mental health are underway. <\/p>\n<p class=\"c-paragraph b-article-body-skinny\">\u201cWe are doing a little work on exploring different mechanistic targets for future development of our strain BMB18 with clinical trials now underway to understand better if the strain could be used for certain health targets or conditions not currently supported effectively by other interventions in areas where novel, high-value IP opportunities exist. This is a big product development project that we are running to support Biome and Activated Probiotics into the future,\u201d he said. <\/p>\n","protected":false},"excerpt":{"rendered":"One of the biggest transformations, said Founder, CEO and Managing Director Blair Vega Norfolk, was how cross-border e-commerce&hellip;\n","protected":false},"author":2,"featured_media":1056789,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4318],"tags":[11246,285009,22477,1493,285010,97685,7371,372,12272,2342,31918,27110,15454,12274,105,4348,51066,54611,285011,4554,32505,233,4434,256179,8583,222,20090,16,15,2488],"class_list":["post-1056788","post","type-post","status-publish","format-standard","has-post-thumbnail","category-nutrition","tag-analysis","tag-axis","tag-background","tag-bacteria","tag-checkup","tag-copy-space","tag-diagnosis","tag-diet","tag-digestion","tag-disease","tag-find","tag-focus","tag-glass","tag-gut","tag-health","tag-healthcare","tag-human","tag-link","tag-magnifying","tag-medical","tag-mental","tag-neurology","tag-nutrition","tag-organ","tag-probiotics","tag-psychology","tag-system","tag-uk","tag-united-kingdom","tag-wellness"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116831547992945984","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1056788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=1056788"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/1056788\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/1056789"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=1056788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=1056788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=1056788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}